Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
about
Relapse of lymphoma after allogeneic hematopoietic cell transplantation: management strategies and outcome.Skin and kidney histological changes in graft-versus-host disease (GVHD) after kidney transplantation.Ocular manifestations of graft-versus-host disease: 10 years' experience.Methodologic Considerations in the Application of Next-Generation Sequencing of Human TRB Repertoires for Clinical Use.Great promise of tissue-resident adult stem/progenitor cells in transplantation and cancer therapiesTwenty years of experience on stem cell transplantation in iran.The impact of HLA-matching on reduced intensity conditioning regimen unrelated donor allogeneic stem cell transplantation for acute myeloid leukemia in patients above 50 years-a report from the EBMT acute leukemia working party.Blood concentration of cyclosporine during early post-transplant period may have influence on the occurrence of chronic graft versus host disease in patients who received allogeneic hematopoietic stem cell transplantationMultipotent Mesenchymal Stromal Cells for the Prophylaxis of Acute Graft-versus-Host Disease-A Phase II Study.Maintenance of host leukocytes in peripheral immune compartments following lethal irradiation and bone marrow reconstitution: implications for graft versus host disease.Dynamical system modeling to simulate donor T cell response to whole exome sequencing-derived recipient peptides: Understanding randomness in alloreactivity incidence following stem cell transplantation.
P2860
Q35093521-FA68AD36-D103-4552-95F2-C8FF1BEEF083Q35184754-353E76FD-5B12-4076-A263-8FCA7464B0E5Q35841541-71FBA869-A40F-4797-9740-87BF0736F215Q36183310-F5AD4AAA-BA49-4B63-990A-CB84C249B11CQ36819400-F41790C0-7B75-423E-81CF-3BBE916D44DCQ36839332-84F0AA52-1958-4D47-AD97-EECC1AB9ECFCQ37148409-FAD4D843-E9F5-4F97-BF79-95DB418555B5Q37644959-B63EC171-9BF7-43B0-AFD7-7C59633D4037Q40235917-87AA9FDC-2676-47C1-891A-64E244102815Q40264417-E4193D98-BAC3-4E46-9CF4-B832CEBA7D9EQ45074498-524B0685-D141-487D-9C12-093AFBF3A548
P2860
Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Alloreactivity as therapeutic ...... nonmyeloablative conditioning.
@en
type
label
Alloreactivity as therapeutic ...... nonmyeloablative conditioning.
@en
prefLabel
Alloreactivity as therapeutic ...... nonmyeloablative conditioning.
@en
P1476
Alloreactivity as therapeutic ...... nonmyeloablative conditioning.
@en
P2093
Søren Lykke Petersen
P304
P577
2007-05-01T00:00:00Z